BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 22898598)

  • 41. iPSC-derived mesenchymal stromal cells are less supportive than primary MSCs for co-culture of hematopoietic progenitor cells.
    Vasko T; Frobel J; Lubberich R; Goecke TW; Wagner W
    J Hematol Oncol; 2016 Apr; 9():43. PubMed ID: 27098268
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immortalization of bone marrow-derived human mesenchymal stem cells by removable simian virus 40T antigen gene: analysis of the ability to support expansion of cord blood hematopoietic progenitor cells.
    Nishioka K; Fujimori Y; Hashimoto-Tamaoki T; Kai S; Qiu H; Kobayashi N; Tanaka N; Westerman KA; Leboulch P; Hara H
    Int J Oncol; 2003 Oct; 23(4):925-32. PubMed ID: 12963970
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reversibility of CD34 expression on human hematopoietic stem cells that retain the capacity for secondary reconstitution.
    Dao MA; Arevalo J; Nolta JA
    Blood; 2003 Jan; 101(1):112-8. PubMed ID: 12393633
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ex vivo expansion of apheresis-derived peripheral blood hematopoietic progenitors.
    Estrov Z; Huh YO; Ginsberg CF; Harris D; Van Q; Mirza NQ; Talpaz M; Korbling M
    J Clin Apher; 2002; 17(1):7-16. PubMed ID: 11948700
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differentiation of hematopoietic progenitor cells towards the myeloid and B-lymphoid lineage by hepatocyte growth factor (HGF) and thrombopoietin (TPO) together with early acting cytokines.
    Grassinger J; Mueller G; Zaiss M; Kunz-Schughart LA; Andreesen R; Hennemann B
    Eur J Haematol; 2006 Aug; 77(2):134-44. PubMed ID: 16856909
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transient in vivo beta-globin production after lentiviral gene transfer to hematopoietic stem cells in the nonhuman primate.
    Hayakawa J; Ueda T; Lisowski L; Hsieh MM; Washington K; Phang O; Metzger M; Krouse A; Donahue RE; Sadelain M; Tisdale JF
    Hum Gene Ther; 2009 Jun; 20(6):563-72. PubMed ID: 19222366
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Extensive generation of human cord blood CD34(+) stem cells from Lin(-)CD34(-) cells in a long-term in vitro system.
    Ando K; Nakamura Y; Chargui J; Matsuzawa H; Tsuji T; Kato S; Hotta T
    Exp Hematol; 2000 Jun; 28(6):690-9. PubMed ID: 10880755
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacological inhibition of AKT activity in human CD34
    Chen S; Gao R; Kobayashi M; Yu H; Yao C; Kapur R; Yoder MC; Liu Y
    Exp Hematol; 2017 Jan; 45():74-84. PubMed ID: 27645691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dual SP/ALDH functionalities refine the human hematopoietic Lin-CD34+CD38- stem/progenitor cell compartment.
    Pierre-Louis O; Clay D; Brunet de la Grange P; Blazsek I; Desterke C; Guerton B; Blondeau C; Malfuson JV; Prat M; Bennaceur-Griscelli A; Lataillade JJ; Le Bousse-Kerdilès MC
    Stem Cells; 2009 Oct; 27(10):2552-62. PubMed ID: 19650038
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effect of anti-CD52 antibody alemtuzumab on ex-vivo culture of umbilical cord blood stem cells.
    Lim CK; Sun L; Feng Q; Law P; Chua WT; Lim SN; Hwang WY
    J Hematol Oncol; 2008 Oct; 1():19. PubMed ID: 18947412
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Changes in the growth properties of CD34+, CD38- bone marrow progenitors during human fetal development.
    Waller EK; Huang S; Terstappen L
    Blood; 1995 Jul; 86(2):710-8. PubMed ID: 7541673
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
    Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Multiple myeloma-related deregulation of bone marrow-derived CD34(+) hematopoietic stem and progenitor cells.
    Bruns I; Cadeddu RP; Brueckmann I; Fröbel J; Geyh S; Büst S; Fischer JC; Roels F; Wilk CM; Schildberg FA; Hünerlitürkoglu AN; Zilkens C; Jäger M; Steidl U; Zohren F; Fenk R; Kobbe G; Brors B; Czibere A; Schroeder T; Trumpp A; Haas R
    Blood; 2012 Sep; 120(13):2620-30. PubMed ID: 22517906
    [TBL] [Abstract][Full Text] [Related]  

  • 54. CD34+ endothelial cell lines derived from murine yolk sac induce the proliferation and differentiation of yolk sac CD34+ hematopoietic progenitors.
    Fennie C; Cheng J; Dowbenko D; Young P; Lasky LA
    Blood; 1995 Dec; 86(12):4454-67. PubMed ID: 8541534
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of members of the Wnt gene family in human hematopoiesis.
    Van Den Berg DJ; Sharma AK; Bruno E; Hoffman R
    Blood; 1998 Nov; 92(9):3189-202. PubMed ID: 9787155
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Improving Gene Therapy Efficiency through the Enrichment of Human Hematopoietic Stem Cells.
    Masiuk KE; Brown D; Laborada J; Hollis RP; Urbinati F; Kohn DB
    Mol Ther; 2017 Sep; 25(9):2163-2175. PubMed ID: 28663101
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Expression of P16 cell cycle inhibitor in human cord blood CD34+ expanded cells following co-culture with bone marrow-derived mesenchymal stem cells.
    Oodi A; Noruzinia M; Habibi Roudkenar M; Nikougoftar M; Soltanpour MS; Khorshidfar M; Amirizadeh N
    Hematology; 2012 Nov; 17(6):334-40. PubMed ID: 22989929
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HES1 inhibits cycling of hematopoietic progenitor cells via DNA binding.
    Yu X; Alder JK; Chun JH; Friedman AD; Heimfeld S; Cheng L; Civin CI
    Stem Cells; 2006 Apr; 24(4):876-88. PubMed ID: 16513761
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular Analysis of Neutrophil Differentiation from Human Induced Pluripotent Stem Cells Delineates the Kinetics of Key Regulators of Hematopoiesis.
    Sweeney CL; Teng R; Wang H; Merling RK; Lee J; Choi U; Koontz S; Wright DG; Malech HL
    Stem Cells; 2016 Jun; 34(6):1513-26. PubMed ID: 26866427
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A novel protocol that allows short-term stem cell expansion of both committed and pluripotent hematopoietic progenitor cells suitable for clinical use.
    Astori G; Malangone W; Adami V; Risso A; Dorotea L; Falasca E; Marini L; Spizzo R; Bigi L; Sala P; Tonutti E; Biffoni F; Rinaldi C; Del Frate G; Pittino M; Degrassi A
    Blood Cells Mol Dis; 2001; 27(4):715-24; discussion 725-7. PubMed ID: 11778655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.